The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (12): 1879-1884.doi: 10.3969/j.issn.1006-5725.2025.12.016
• Clinical Research • Previous Articles
Received:
2025-03-14
Online:
2025-06-25
Published:
2025-07-02
Contact:
Yiwen SHI
E-mail:1109779491@qq.com
CLC Number:
Jiaxin YAN,Yiwen SHI. The correlation between salivary IL⁃33, anti⁃salivary gland protein⁃1 antibody levels and salivary gland injury in primary Sjogren′s syndrome[J]. The Journal of Practical Medicine, 2025, 41(12): 1879-1884.
Tab.2
Comparison of the clinical data of the observation and control groups"
临床资料 | 观察组(n = 91) | 对照组(n = 42) | t/ | P值 |
---|---|---|---|---|
性别/[例(%)] | 0.009 | 0.925 | ||
男 | 4(4.40) | 2(4.76) | ||
女 | 87(95.60) | 40(95.24) | ||
年龄/岁 | 46.72 ± 8.53 | 46.13 ± 8.97 | 0.365 | 0.716 |
病程/年 | 4.78 ± 0.76 | - | - | - |
动态唾液流速/(mL/min) | 0.54 ± 0.11 | 1.37 ± 0.28 | 24.549 | < 0.001 |
静态唾液流速/(mL/min) | 0.13 ± 0.04 | 0.69 ± 0.17 | 20.008 | < 0.001 |
颌下腺SGUS评分≥ 2分/[例(%)] | 50(54.95) | 0(0.00) | - | - |
腮腺SGUS评分≥ 2分/[例(%)] | 55(60.44) | 0(0.00) | - | - |
IgG/(g/L) | 28.41 ± 5.78 | 18.67 ± 4.32 | 10.822 | < 0.001 |
补体C4/(g/L) | 0.20 ± 0.05 | 0.21 ± 0.06 | 1.005 | 0.317 |
补体C3/(g/L) | 0.92 ± 0.17 | 0.94 ± 0.19 | 0.607 | 0.545 |
淋巴细胞计数/(个/μL) | 1 225.41 ± 138.57 | 1 243.26 ± 140.89 | 0.687 | 0.493 |
NK细胞计数/(个/μL) | 121.37 ± 14.85 | 126.83 ± 15.74 | 1.934 | 0.055 |
中性粒细胞计数/(个/μL) | 2 767.41 ± 386.23 | 1 213.08 ± 179.56 | 24.834 | < 0.001 |
CD8+ T细胞计数/(个/μL) | 421.03 ± 45.89 | 425.34 ± 46.37 | 0.502 | 0.617 |
单核细胞计数/(个/μL) | 321.06 ± 33.79 | 317.13 ± 32.14 | 0.633 | 0.528 |
CD4+细胞计数/(个/μL) | 361.08 ± 38.45 | 302.13 ± 31.18 | 8.698 | < 0.001 |
Tab.5
Correlation of salivary IL-33 and anti-SP-1 antibody levels with salivary flow rate, clinical indicators and SGUS scores in pSS patients analysed"
指标 | 唾液IL-33 | 抗SP-1抗体 | ||
---|---|---|---|---|
r值 | P值 | r值 | P值 | |
动态唾液流速 | 0.565 | < 0.001 | 0.551 | < 0.001 |
静态唾液流速 | 0.524 | < 0.001 | 0.530 | < 0.001 |
IgG | 0.317 | 0.087 | 0.265 | 0.123 |
中性粒细胞计数 | 0.271 | 0.119 | 0.220 | 0.257 |
CD4+细胞计数 | 0.476 | 0.005 | 0.461 | 0.003 |
SGUS评分 | 0.574 | < 0.001 | 0.627 | < 0.001 |
1 |
NEGRINI S, EMMI G, GRECO M, et al. Sjogren's syndrome: A systemic autoimmune disease[J]. Clin Exp Med, 2022,22(1):9-25. doi:10.1007/s10238-021-00728-6
doi: 10.1007/s10238-021-00728-6 |
2 |
苏敏,苏珊,宋书林,等. 原发性干燥综合征临床特点与细胞因子相关性[J]. 实用医学杂志,2023,39(16):2106-2111. doi:10.3969/j.issn.1006-5725.2023.16.016
doi: 10.3969/j.issn.1006-5725.2023.16.016 |
3 |
LU L, DAI T, ZHAO Y, et al. The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome[J]. Clin Rheumatol, 2024,43(5):1675-1682. doi:10.1007/s10067-024-06935-2
doi: 10.1007/s10067-024-06935-2 |
4 |
ZHANG N, ZHANG H, BAO X, et al. Transactivation DNA-binding protein-related genes were associated with salivary gland injury in primary Sjogren syndrome[J]. Medicine (Baltimore), 2024,103(39):e39827. doi:10.1097/md.0000000000039827
doi: 10.1097/md.0000000000039827 |
5 | 董源基. IL-33/ST2轴在干燥综合征唾液腺损伤中的作用及机制[D]. 武汉:华中科技大学,2022. |
6 | 李子轲. SP1在干燥综合征中的作用的研究[D]. 武汉:华中科技大学,2021. |
7 |
SHIBOSKI C H, SHIBOSKI S C, SEROR R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts[J]. Ann Rheum Dis, 2017,76(1):9-16. doi:10.1002/art.39859
doi: 10.1002/art.39859 |
8 |
MIN H K, KIM S H, LEE K A, et al. Correlation between salivary gland ultrasonography and scintigraphy in primary Sjogren's syndrome[J]. Rheumatology (Oxford), 2022,61(8):3414-3419. doi:10.1093/rheumatology/keab881
doi: 10.1093/rheumatology/keab881 |
9 |
BENCHABANE S, SLIMANI-KADDOURI A, ACHELI D, et al. Association between increased Bcl-2, Fas and FasL levels and inflammation extent in labial salivary glands during primary sjogren's syndrome[J]. Endocr Metab Immune Disord Drug Targets, 2022,22(3):328-338. doi:10.2174/1871530321666210809155147
doi: 10.2174/1871530321666210809155147 |
10 |
ZHANG N, JI C, PENG X, et al. Bioinformatics analysis identified immune infiltration, risk and drug prediction models of copper-induced death genes involved in salivary glands damage of primary Sjogren's syndrome[J]. Medicine (Baltimore), 2022,101(41):e31050. doi:10.1097/md.0000000000031050
doi: 10.1097/md.0000000000031050 |
11 |
HYNNE H, AQRAWI L A, JENSEN J L, et al. Proteomic profiling of saliva and tears in radiated head and neck cancer patients as compared to primary sjogren's syndrome patients[J]. Int J Mol Sci, 2022,23(7):3714. doi:10.3390/ijms23073714
doi: 10.3390/ijms23073714 |
12 | 王静,李飞,黄毅,等. 原发性干燥综合征患者唾液胱抑素D水平与唾液腺损伤的相关性分析[J]. 陆军军医大学学报,2024,46(21):2451-2456. |
13 | NAYERI T, SARVI S, DARYANI A. Saliva and tear as useful tools for the diagnosis of Toxoplasma gondii in human specimens: A systematic review[J]. Ann Parasitol, 2022,68(2):201-213. |
14 |
KATAYAMA Y, MURAI R, MORIAI M, et al. Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection?[J]. J Infect Chemother, 2022,28(7):1012-1014. doi:10.1016/j.jiac.2022.03.009
doi: 10.1016/j.jiac.2022.03.009 |
15 |
FERRIER C, BENDIFALLAH S, SUISSE S, et al. Saliva microRNA signature to diagnose endometriosis: A cost-effectiveness evaluation of the Endotest(R)[J]. BJOG, 2023,130(4):396-406. doi:10.1111/1471-0528.17348
doi: 10.1111/1471-0528.17348 |
16 |
NONAKA T, WONG D. Saliva Diagnostics[J]. Annu Rev Anal Chem (Palo Alto Calif), 2022,15(1):107-121. doi:10.1146/annurev-anchem-061020-123959
doi: 10.1146/annurev-anchem-061020-123959 |
17 |
AQRAWI L A, GALTUNG H K, GUERREIRO E M, et al. Proteomic and histopathological characterisation of sicca subjects and primary Sjogren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers[J]. Arthritis Res Ther, 2019,21(1):181. doi:10.1186/s13075-019-1961-4
doi: 10.1186/s13075-019-1961-4 |
18 |
ZHOU Y, XU Z, LIU Z. Role of IL-33-ST2 pathway in regulating inflammation: Current evidence and future perspectives[J]. J Transl Med, 2023,21(1):902. doi:10.1186/s12967-023-04782-4
doi: 10.1186/s12967-023-04782-4 |
19 | 张艳,姚巧玲,宋海辰,等. IL-33在哮喘合并间歇性缺氧发病过程中的作用[J]. 新疆医科大学学报,2023,46(10):1278-1284. |
20 |
TARUSELLI M T, ABDUL Q A, ABEBAYEHU D, et al. IL-33 induces cellular and exosomal miR-146a expression as a feedback inhibitor of mast cell function[J]. J Immunol, 2024,212(8):1277-1286. doi:10.4049/jimmunol.2200916
doi: 10.4049/jimmunol.2200916 |
21 |
SARRAND J, BAGLIONE L, PARISIS D, et al. The involvement of alarmins in the pathogenesis of sjogren's syndrome[J]. Int J Mol Sci, 2022,23(10):5671. doi:10.3390/ijms23105671
doi: 10.3390/ijms23105671 |
22 | 王小宇. 探索抗水通道蛋白1和5抗体在原发性干燥综合征的诊断价值[D]. 重庆: 陆军军医大学,2023. |
23 |
CHEN Y, LUO X, DENG C, et al. Immunometabolic alteration of CD4(+) T cells in the pathogenesis of primary Sjogren's syndrome[J]. Clin Exp Med, 2024,24(1):163. doi:10.1007/s10238-024-01429-6
doi: 10.1007/s10238-024-01429-6 |
24 |
FIDELIX T, CZAPKOWSKI A, AZJEN S, et al. Salivary gland ultrasonography as a predictor of clinical activity in Sjogren's syndrome[J]. PLoS One, 2017,12(8):e182287. doi:10.1371/journal.pone.0182287
doi: 10.1371/journal.pone.0182287 |
25 |
MOSSEL E, VAN NIMWEGEN J F, STEL A J, et al. Clinical phenotyping of primary sjogren syndrome patients using salivary gland ultrasonography: Data from the RESULT cohort[J]. J Rheumatol, 2021,48(5):717-727. doi:10.3899/jrheum.200482
doi: 10.3899/jrheum.200482 |
26 | 侯鸣, 李有强, 李雪梅,等. 基于胸部CT及临床特征构建原发性干燥综合征患者肺脏受累的风险预测模型[J]. 实用医学杂志,2024,40(3):400-405. |
27 | LEE K A, LEE S H, KIM H R. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjogren's syndrome[J]. Clin Exp Rheumatol, 2018,112(3):165-172. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||